Domača stranOPL • ASX
add
Opyl Ltd
Prejšnji trg. dan.
0,019 $
Letni razpon
0,014 $ - 0,033 $
Tržna kapitalizacija
2,75 mio. AUD
Povprečni obseg
110,33 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
ASX
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (AUD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 167,72 tis. | 37,65 % |
Stroški poslovanja | 323,38 tis. | 42,41 % |
Čisti dohodek | −341,60 tis. | 46,47 % |
Čista dobičkovnost prihodkov | −203,67 | 61,11 % |
Earnings per share | — | — |
EBITDA | −318,04 tis. | 25,38 % |
Efektivna davčna stopnja | — | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (AUD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 329,55 tis. | −43,64 % |
Skupna sredstva | 384,82 tis. | −41,63 % |
Skupne obveznosti | 695,82 tis. | −3,76 % |
Celoten lastniški kapital | −310,99 tis. | — |
Shares outstanding | 170,80 mio. | — |
Razmerje P/B | ∞ | — |
Donosnost sredstev | −208,46 % | — |
Donosnost kapitala | −683,20 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (AUD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −341,60 tis. | 46,47 % |
Denar iz dejavnosti | −309,99 tis. | −6,88 % |
Denar iz naložb | −662,00 | — |
Denar iz financiranja | 288,10 tis. | −19,06 % |
Neto sprememba denarnih sredstev | −22,55 tis. | −134,21 % |
Prost denarni tok | −200,74 tis. | 18,01 % |
Vizitka
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Datum ustanovitve
2013
Spletno mesto
Zaposleni
3
